News | August 10, 2010

Therapeutic Hypothermia Conference Helps Hospital Develop Cooling Programs

August 9, 2010 - Health care professionals will attend a conference devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other national experts,

Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patients conference will take place September 9 to 10, in Minneapolis, Minn.

“We’ve developed the key elements of a successful resuscitation program: an organized network, collaborative care, established data measurements and feedback to all parties,” said Michael Mooney, M.D. “We are sharing what we’ve learned with physicians and hospitals who are just beginning therapeutic hypothermia programs and with those who want to expand existing programs.”

Mooney is an interventional cardiologist and co-director of the Cool It program of the Minneapolis Heart Institute at Abbott Northwestern Hospital. The hospital is a pioneer in using cooling to treat comatose patients following cardiac arrest. From its 2006 inception, the Cool It program focused on developing a collaborative model within a network.

“The cardiac arrest patient is a true example of why a large multi-discipline approach is needed to care for these critically ill patients,” says Barbara Tate Unger, R.N., development director, systems of cardiovascular emergency care at the Minneapolis Heart Institute at Abbott Northwestern.“As the patient is handed from paramedics to emergency departments to intensive care units to cardiologists to rehabilitation specialists, understanding the role that each must play is critical to great outcomes.”

Thirty-three hospitals and 10 clinics follow the "Cool It" protocol. Paramedics throughout Minnesota and emergency departments as far away as 200 miles from Minneapolis are working together to begin care at the earliest possible moment.

For more information: www.allina.com

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init